ADCY6是一种潜在的预后生物标志物,通过Hippo信号通路抑制了OTSCC的进展
Sen Yang1,2, Li-Juan Guo3, Yong Liang4
1Department of Stomatology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
腺酸环酶6 (ADCY6) 在口腔舌状细胞癌 (OTSCC) 中降低调节,对患者的预后产生负面影响. 升级ADCY6通过调节河马信号通路来抑制瘤生长和转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 口腔舌状细胞癌 (OTSCC) 是癌症死亡的一个重要原因.
- 腺酸环酶6 (ADCY6) 与各种致命瘤的发展有关.
- ADCY6在OTSCC病原体中的特定作用以前是未定义的.
研究的目的:
- 研究OTSCC中ADCY6的表达和临床意义.
- 阐明ADCY6在OTSCC细胞系中的功能作用.
- 探索ADCY6影响OTSCC进展的潜在分子机制,特别是它与Hippo信号通路的相互作用.
主要方法:
- 在OTSCC组织和细胞系中对ADCY6表达的定量分析.
- 在ADCY6表达和临床参数 (TNM阶段,瘤大小) 之间的统计相关性分析.
- 在体外功能测定 (增殖,迁移,入侵,亡) 和体内皮下瘤生成测定.
- 西部斑点 (WB) 测试和细胞功能恢复测试,以调查信号通路,重点关注河马通路.
主要成果:
- 与正常对照组相比,ADCY6表达在OTSCC组织和细胞系中显著下调.
- 较低的ADCY6表达与高级TNM阶段,较大的瘤大小和较差的患者预后相关.
- 过度表达ADCY6抑制了OTSCC细胞的增殖,迁移和入侵,同时促进了细胞亡.
- 发现ADCY6的上调会损害Hippo信号通路,从而减少OTSCC的恶性生物行为.
结论:
- 在OTSCC中,ADCY6充当瘤抑制剂.
- 通过涉及河马信号通路的机制,ADCY6的下调有助于OTSCC的进展.
- ADCY6代表了OTSCC治疗的潜在治疗标.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
相关概念视频
Hedgehog Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
